Association of type 2 diabetes mellitus and seroprevalence for cytomegalovirus

Bertram W. Roberts, Irina Cech

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Background: Infection is known to play a role in type 1 diabetes, but there is a paucity of information on its role in diabetes mellitus type 2. We examined the seroprevalence of selected viruses in a group of predominantly Hispanic patients with type 2 diabetes and control subjects without diabetes. Methods: One hundred thirteen patients, 83 with type 2 diabetes and 30 control subjects, all undergoing hemodialysis at the same facility in San Antonio, Texas, were tested for antibodies against coxsackie B viruses, cytomegalovirus (CMV), and parvovirus. Sixty-six of these patients and 25 control subjects were tested bimonthly for 6 months. Results: We observed a greater seroprevalence of anti-CMV IgG antibodies among patients with diabetes (97.6%), compared with control subjects (86.7%), and the difference was statistically significant [OR = 6.2, 95% CI: 1.1 to 36.0, P < 0.05]. Three draws on a subset of 91 patients produced still greater odds [OR = 12.4, 95% CI: 1.3 to 117, P < 0.05]. There were significantly more (P ≤ 0.001) vascular complications among patients with diabetes. There was a colinearity of trends between diabetes, seropositivity to CMV, and age. Conclusions: Our findings indicated an up to 12 times greater odds of having type 2 diabetes for persons previously exposed to CMV. Since accelerated atherosclerosis is also associated with diabetes and CMV, past CMV infection may be a common factor that links atherosclerosis and diabetes. No other viruses tested in this study, either coxsackie B viruses or parvovirus, showed a significant association with type 2 diabetes.

Original languageEnglish (US)
Pages (from-to)686-692
Number of pages7
JournalSouthern Medical Journal
Volume98
Issue number7
DOIs
StatePublished - Jul 2005
Externally publishedYes

Fingerprint

Seroepidemiologic Studies
Cytomegalovirus
Type 2 Diabetes Mellitus
Human Enterovirus B
Parvovirus
Atherosclerosis
Viruses
Antibodies
Cytomegalovirus Infections
Type 1 Diabetes Mellitus
Hispanic Americans
Blood Vessels
Renal Dialysis
Infection

Keywords

  • Age
  • Atherosclerosis
  • Coxsackie B viruses
  • Cytomegalovirus
  • Hemodialysis
  • Mexican Americans
  • Parvovirus
  • Type 2 diabetes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Association of type 2 diabetes mellitus and seroprevalence for cytomegalovirus. / Roberts, Bertram W.; Cech, Irina.

In: Southern Medical Journal, Vol. 98, No. 7, 07.2005, p. 686-692.

Research output: Contribution to journalArticle

Roberts, Bertram W. ; Cech, Irina. / Association of type 2 diabetes mellitus and seroprevalence for cytomegalovirus. In: Southern Medical Journal. 2005 ; Vol. 98, No. 7. pp. 686-692.
@article{cd316e83876f46548a8ddc677caea4fb,
title = "Association of type 2 diabetes mellitus and seroprevalence for cytomegalovirus",
abstract = "Background: Infection is known to play a role in type 1 diabetes, but there is a paucity of information on its role in diabetes mellitus type 2. We examined the seroprevalence of selected viruses in a group of predominantly Hispanic patients with type 2 diabetes and control subjects without diabetes. Methods: One hundred thirteen patients, 83 with type 2 diabetes and 30 control subjects, all undergoing hemodialysis at the same facility in San Antonio, Texas, were tested for antibodies against coxsackie B viruses, cytomegalovirus (CMV), and parvovirus. Sixty-six of these patients and 25 control subjects were tested bimonthly for 6 months. Results: We observed a greater seroprevalence of anti-CMV IgG antibodies among patients with diabetes (97.6{\%}), compared with control subjects (86.7{\%}), and the difference was statistically significant [OR = 6.2, 95{\%} CI: 1.1 to 36.0, P < 0.05]. Three draws on a subset of 91 patients produced still greater odds [OR = 12.4, 95{\%} CI: 1.3 to 117, P < 0.05]. There were significantly more (P ≤ 0.001) vascular complications among patients with diabetes. There was a colinearity of trends between diabetes, seropositivity to CMV, and age. Conclusions: Our findings indicated an up to 12 times greater odds of having type 2 diabetes for persons previously exposed to CMV. Since accelerated atherosclerosis is also associated with diabetes and CMV, past CMV infection may be a common factor that links atherosclerosis and diabetes. No other viruses tested in this study, either coxsackie B viruses or parvovirus, showed a significant association with type 2 diabetes.",
keywords = "Age, Atherosclerosis, Coxsackie B viruses, Cytomegalovirus, Hemodialysis, Mexican Americans, Parvovirus, Type 2 diabetes",
author = "Roberts, {Bertram W.} and Irina Cech",
year = "2005",
month = "7",
doi = "10.1097/01.SMJ.0000163310.12516.2D",
language = "English (US)",
volume = "98",
pages = "686--692",
journal = "Southern Medical Journal",
issn = "0038-4348",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Association of type 2 diabetes mellitus and seroprevalence for cytomegalovirus

AU - Roberts, Bertram W.

AU - Cech, Irina

PY - 2005/7

Y1 - 2005/7

N2 - Background: Infection is known to play a role in type 1 diabetes, but there is a paucity of information on its role in diabetes mellitus type 2. We examined the seroprevalence of selected viruses in a group of predominantly Hispanic patients with type 2 diabetes and control subjects without diabetes. Methods: One hundred thirteen patients, 83 with type 2 diabetes and 30 control subjects, all undergoing hemodialysis at the same facility in San Antonio, Texas, were tested for antibodies against coxsackie B viruses, cytomegalovirus (CMV), and parvovirus. Sixty-six of these patients and 25 control subjects were tested bimonthly for 6 months. Results: We observed a greater seroprevalence of anti-CMV IgG antibodies among patients with diabetes (97.6%), compared with control subjects (86.7%), and the difference was statistically significant [OR = 6.2, 95% CI: 1.1 to 36.0, P < 0.05]. Three draws on a subset of 91 patients produced still greater odds [OR = 12.4, 95% CI: 1.3 to 117, P < 0.05]. There were significantly more (P ≤ 0.001) vascular complications among patients with diabetes. There was a colinearity of trends between diabetes, seropositivity to CMV, and age. Conclusions: Our findings indicated an up to 12 times greater odds of having type 2 diabetes for persons previously exposed to CMV. Since accelerated atherosclerosis is also associated with diabetes and CMV, past CMV infection may be a common factor that links atherosclerosis and diabetes. No other viruses tested in this study, either coxsackie B viruses or parvovirus, showed a significant association with type 2 diabetes.

AB - Background: Infection is known to play a role in type 1 diabetes, but there is a paucity of information on its role in diabetes mellitus type 2. We examined the seroprevalence of selected viruses in a group of predominantly Hispanic patients with type 2 diabetes and control subjects without diabetes. Methods: One hundred thirteen patients, 83 with type 2 diabetes and 30 control subjects, all undergoing hemodialysis at the same facility in San Antonio, Texas, were tested for antibodies against coxsackie B viruses, cytomegalovirus (CMV), and parvovirus. Sixty-six of these patients and 25 control subjects were tested bimonthly for 6 months. Results: We observed a greater seroprevalence of anti-CMV IgG antibodies among patients with diabetes (97.6%), compared with control subjects (86.7%), and the difference was statistically significant [OR = 6.2, 95% CI: 1.1 to 36.0, P < 0.05]. Three draws on a subset of 91 patients produced still greater odds [OR = 12.4, 95% CI: 1.3 to 117, P < 0.05]. There were significantly more (P ≤ 0.001) vascular complications among patients with diabetes. There was a colinearity of trends between diabetes, seropositivity to CMV, and age. Conclusions: Our findings indicated an up to 12 times greater odds of having type 2 diabetes for persons previously exposed to CMV. Since accelerated atherosclerosis is also associated with diabetes and CMV, past CMV infection may be a common factor that links atherosclerosis and diabetes. No other viruses tested in this study, either coxsackie B viruses or parvovirus, showed a significant association with type 2 diabetes.

KW - Age

KW - Atherosclerosis

KW - Coxsackie B viruses

KW - Cytomegalovirus

KW - Hemodialysis

KW - Mexican Americans

KW - Parvovirus

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=23044488801&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23044488801&partnerID=8YFLogxK

U2 - 10.1097/01.SMJ.0000163310.12516.2D

DO - 10.1097/01.SMJ.0000163310.12516.2D

M3 - Article

VL - 98

SP - 686

EP - 692

JO - Southern Medical Journal

JF - Southern Medical Journal

SN - 0038-4348

IS - 7

ER -